Method for transmyocardial revascularization

Surgery – Miscellaneous – Methods

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

606 15, A61N 506

Patent

active

058733663

ABSTRACT:
A method for performing transmyocardial revascularization (TMR) uses a cardioplegic agent to briefly stop the heartbeat long enough to create 10 to 40 carefully placed transmyocardial blood flow channels using a laser. The cardioplegic agent used may be adenosine or an adenosine triphosphate-sensitive potassium channel opener, such as aprikalim, or a standard hyperkalemic cardioplegic agent. The temporarily induced motionlessness of the heart allows accurate and efficient placement of the blood flow channels, while the short duration of the cardioplegic effect obviates the need for cardiopulmonary bypass. The blood flow channels can be formed from the exterior or the interior of the heart. Preferably, the TMR procedure is performed using an infrared laser, such as a CO.sub.2 laser with an articulated-arm waveguide or a pulsed Nd:YAG laser with a flexible fiberoptic delivery system, or a near infrared laser, such as a holmium:YAG or erbium laser with a flexible fiberoptic delivery system, because of their ability to efficiently ablate clearly defined passages through myocardial tissue without inducing significant thermal damage to the surrounding myocardium. The laser delivery device or a separate probe can be used to verify the depth of the blood flow channels and their connection with the ventricular chamber. The heart resumes beating spontaneously after reperfusion, with no need for defibrillation or cardioversion. The TMR procedure can be performed by a cardiac or thoracic surgeon using standard open-chest surgical techniques or using a minimally invasive surgical approach or by an interventional cardiologist using a percutaneous transluminal intravascular approach.

REFERENCES:
patent: 4658817 (1987-04-01), Hardy
patent: 5125924 (1992-06-01), Rudko
patent: 5125926 (1992-06-01), Rudko
patent: 5380316 (1995-01-01), Aita et al.
patent: 5389096 (1995-02-01), Aita et al.
patent: 5428039 (1995-06-01), Cohen
patent: 5554152 (1996-09-01), Aita et al.
patent: 5554497 (1996-09-01), Raymond
patent: 5607421 (1997-03-01), Jeevanandam et al.
patent: 5695457 (1997-12-01), St. Goar et al.
patent: 5755687 (1998-05-01), Knudson et al.
CardioGenesis Corporation, Percutaneous Myocardial Revascularization, Sep. 1995.
Dorros, G. and Cohn J. M., "Adenosine-Induced Transient Cardiac Asystole Enhances Precise Deployment of Stent-Grafts in the Thoracic or Abdominal Aorta" J Endovasc Surg, Aug. 1996.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Method for transmyocardial revascularization does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for transmyocardial revascularization, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for transmyocardial revascularization will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-299017

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.